JNJ-42153605
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 526854

CAS#: 1254977-87-1

Description: JNJ-42153605 is a potent and selective mGlu2 receptor PAM with an acceptable pharmacokinetic profile in rodent and nonrodent species. JNJ-42153605 showed centrally mediated in vivo effectivity in models sensitive to mGlu2 receptor modulation such as sleep−wake electroencephalogram (sw-EEG) in rats,34 showing suppressed REM sleep during the first 4 h after oral administration of a 3 mg/kg dose.


Chemical Structure

img
JNJ-42153605
CAS# 1254977-87-1

Theoretical Analysis

MedKoo Cat#: 526854
Name: JNJ-42153605
CAS#: 1254977-87-1
Chemical Formula: C22H23F3N4
Exact Mass: 400.1875
Molecular Weight: 400.4492
Elemental Analysis: C, 65.99; H, 5.79; F, 14.23; N, 13.99

Price and Availability

Size Price Availability Quantity
25.0mg USD 250.0 2 Weeks
50.0mg USD 450.0 2 Weeks
100.0mg USD 750.0 2 Weeks
200.0mg USD 1250.0 2 Weeks
500.0mg USD 2250.0 2 Weeks
1.0g USD 3250.0 2 Weeks
2.0g USD 5450.0 2 Weeks
Bulk inquiry

Synonym: JNJ-42153605; JNJ 42153605; JNJ42153605.

IUPAC/Chemical Name: 3-(Cyclopropylmethyl)-7-(4-phenyl-1-piperidinyl)-8-(trifluoromethyl)[1,2,4]triazolo[4,3-a]pyridine

InChi Key: BQAVZGJJQFJSMW-UHFFFAOYSA-N

InChi Code: InChI=1S/C22H23F3N4/c23-22(24,25)20-18(10-13-29-19(14-15-6-7-15)26-27-21(20)29)28-11-8-17(9-12-28)16-4-2-1-3-5-16/h1-5,10,13,15,17H,6-9,11-12,14H2

SMILES Code: FC(C1=C(N2CCC(C3=CC=CC=C3)CC2)C=CN4C1=NN=C4CC5CC5)(F)F

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 400.4492 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Ahnaou A, Lavreysen H, Tresadern G, Cid JM, Drinkenburg WH. mGlu2 Receptor
Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards
Their Primary Efficacy on Sleep Measures in Rats. PLoS One. 2015 Dec
11;10(12):e0144017. doi: 10.1371/journal.pone.0144017. eCollection 2015. PubMed
PMID: 26658273; PubMed Central PMCID: PMC4684355.

2: Lavreysen H, Langlois X, Donck LV, Nuñez JM, Pype S, Lütjens R, Megens A.
Preclinical evaluation of the antipsychotic potential of the mGlu2-positive
allosteric modulator JNJ-40411813. Pharmacol Res Perspect. 2015 Mar;3(2):e00097.
doi: 10.1002/prp2.97. Epub 2015 Jan 30. PubMed PMID: 25692027; PubMed Central
PMCID: PMC4324682.

3: Wyckhuys T, Wyffels L, Langlois X, Schmidt M, Stroobants S, Staelens S. The
[18F]FDG μPET readout of a brain activation model to evaluate the metabotropic
glutamate receptor 2 positive allosteric modulator JNJ-42153605. J Pharmacol Exp
Ther. 2014 Aug;350(2):375-86. doi: 10.1124/jpet.114.213959. Epub 2014 Jun 4.
PubMed PMID: 24898267.

4: Megens AA, Hendrickx HM, Hens KA, Talloen WJ, Lavreysen H. mGlu(2)
receptor-mediated modulation of conditioned avoidance behavior in rats. Eur J
Pharmacol. 2014 Mar 15;727:130-9. doi: 10.1016/j.ejphar.2014.01.044. Epub 2014
Jan 30. PubMed PMID: 24486391.

5: Cid JM, Tresadern G, Vega JA, de Lucas AI, Matesanz E, Iturrino L, Linares ML,
Garcia A, Andrés JI, Macdonald GJ, Oehlrich D, Lavreysen H, Megens A, Ahnaou A,
Drinkenburg W, Mackie C, Pype S, Gallacher D, Trabanco AA. Discovery of
3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4
,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic
glutamate 2 receptor. J Med Chem. 2012 Oct 25;55(20):8770-89. doi:
10.1021/jm3010724. Epub 2012 Oct 16. PubMed PMID: 23072213.